U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1671 - 1680 of 2107 results

nucleic acid
Status:
Investigational
Source:
NCT00042081: Phase 3 Interventional Completed Coronary Artery Disease
(2002)
Source URL:

Class:
NUCLEIC ACID

nucleic acid
Status:
Investigational
Source:
NCT00306904: Phase 2 Interventional Completed Diabetic Macular Edema
(2006)
Source URL:

Class:
NUCLEIC ACID

nucleic acid
Status:
Investigational
Source:
NCT02947867: Phase 2/Phase 3 Interventional Unknown status Ischaemic Central Retinal Vein Occlusion
(2017)
Source URL:

Class:
NUCLEIC ACID

nucleic acid
Status:
Designated
Source:
FDA ORPHAN DRUG:451914
Source URL:

Class:
NUCLEIC ACID

nucleic acid
Status:
Designated
Source:
FDA ORPHAN DRUG:173903
Source URL:

Class:
NUCLEIC ACID

Showing 1671 - 1680 of 2107 results